{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:39:40Z","timestamp":1770691180223,"version":"3.49.0"},"reference-count":219,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["169084"],"award-info":[{"award-number":["169084"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["168960"],"award-info":[{"award-number":["168960"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["38308"],"award-info":[{"award-number":["38308"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Innate lymphoid cells (ILCs) are a family of lymphocytes with essential roles in tissue homeostasis and immunity. Along with other tissue-resident immune populations, distinct subsets of ILCs have important roles in either promoting or inhibiting immune tolerance in a variety of contexts, including cancer and autoimmunity. In solid organ and hematopoietic stem cell transplantation, both donor and recipient-derived ILCs could contribute to immune tolerance or rejection, yet understanding of protective or pathogenic functions are only beginning to emerge. In addition to roles in directing or regulating immune responses, ILCs interface with parenchymal cells to support tissue homeostasis and even regeneration. Whether specific ILCs are tissue-protective or enhance ischemia reperfusion injury or fibrosis is of particular interest to the field of transplantation, beyond any roles in limiting or promoting allograft rejection or graft-versus host disease. Within this review, we discuss the current understanding of ILCs functions in promoting immune tolerance and tissue repair at homeostasis and in the context of transplantation and highlight where targeting or harnessing ILCs could have applications in novel transplant therapies.<\/jats:p>","DOI":"10.1093\/cei\/uxad050","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:03:53Z","timestamp":1682777033000},"page":"23-39","source":"Crossref","is-referenced-by-count":12,"title":["Protective and pathogenic functions of innate lymphoid cells in transplantation"],"prefix":"10.1093","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6709-7802","authenticated-orcid":false,"given":"Martin L","family":"Mak","sequence":"first","affiliation":[{"name":"Department of Immunology, Temerty Faculty of Medicine, University of Toronto , Toronto , Canada"},{"name":"Toronto General Hospital Research Institute, Ajmera Transplant Centre, University Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-9317","authenticated-orcid":false,"given":"Kyle T","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Immunology, Temerty Faculty of Medicine, University of Toronto , Toronto , Canada"},{"name":"Toronto General Hospital Research Institute, Ajmera Transplant Centre, University Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5117-7453","authenticated-orcid":false,"given":"Sarah Q","family":"Crome","sequence":"additional","affiliation":[{"name":"Department of Immunology, Temerty Faculty of Medicine, University of Toronto , Toronto , Canada"},{"name":"Toronto General Hospital Research Institute, Ajmera Transplant Centre, University Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"key":"2023070613574133700_CIT0001","doi-asserted-by":"crossref","first-page":"836999","DOI":"10.3389\/fimmu.2022.836999","article-title":"Tissue-dependent adaptations and functions of innate lymphoid cells","volume":"13","author":"Murphy","year":"2022","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0002","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1172\/JCI124617","article-title":"The balance of power: innate lymphoid cells in tissue inflammation and repair","volume":"129","author":"Castellanos","year":"2019","journal-title":"J Clin Invest"},{"key":"2023070613574133700_CIT0003","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/imm.12098","article-title":"Tissue-specific effector functions of innate lymphoid cells","volume":"139","author":"Bj\u00f6rkstr\u00f6m","year":"2013","journal-title":"Immunology"},{"key":"2023070613574133700_CIT0004","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3389\/fimmu.2017.01422","article-title":"Interactions between innate lymphoid cells and cells of the innate and adaptive immune system","volume":"8","author":"Symowski","year":"2017","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41577-019-0194-8","article-title":"Functional interactions between innate lymphoid cells and adaptive immunity","volume":"19","author":"Sonnenberg","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2023070613574133700_CIT0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/eji.201747294","article-title":"ILC-poiesis: Ensuring tissue ILC differentiation at the right place and time","volume":"49","author":"Lim","year":"2019","journal-title":"Eur J Immunol"},{"key":"2023070613574133700_CIT0007","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","article-title":"Systemic human ILC precursors provide a substrate for tissue ILC differentiation","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"2023070613574133700_CIT0008","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"V\u00e9ly","year":"2016","journal-title":"Nat Immunol"},{"key":"2023070613574133700_CIT0009","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood.2021014654","article-title":"Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG\/JAK3 deficiency","volume":"139","author":"Goncalves","year":"2022","journal-title":"Blood"},{"key":"2023070613574133700_CIT0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0011","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2014.02.033","article-title":"Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures","volume":"133","author":"Gold","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2023070613574133700_CIT0012","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2018.11.002","article-title":"Neuronal regulation of innate lymphoid cells","volume":"56","author":"Klose","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"2023070613574133700_CIT0013","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature16161","article-title":"Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit","volume":"529","author":"von Moltke","year":"2016","journal-title":"Nature"},{"key":"2023070613574133700_CIT0014","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote being of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"key":"2023070613574133700_CIT0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1579-3","article-title":"Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis","volume":"574","author":"Godinho-Silva","year":"2019","journal-title":"Nature"},{"key":"2023070613574133700_CIT0016","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science"},{"key":"2023070613574133700_CIT0017","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.2001304","article-title":"Gut microbiota regulate gut-lung axis inflammatory responses by mediating ILC2 compartmental migration","volume":"207","author":"Pu","year":"2021","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0018","doi-asserted-by":"crossref","first-page":"679509","DOI":"10.3389\/fimmu.2021.679509","article-title":"Migration of lung resident group 2 innate lymphoid cells link allergic lung inflammation and liver immunity","volume":"12","author":"Math\u00e4","year":"2021","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0019","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3389\/fimmu.2019.02010","article-title":"Metabolic control of innate lymphoid cell migration","volume":"10","author":"Willinger","year":"2019","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0020","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"2023070613574133700_CIT0021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2014a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2023070613574133700_CIT0022","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"2023070613574133700_CIT0023","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"2023070613574133700_CIT0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature11813","article-title":"A T-bet gradient controls the fate and function of CCR6-ROR\u03b3t+ innate lymphoid cells","volume":"494","author":"Klose","year":"2013","journal-title":"Nature"},{"key":"2023070613574133700_CIT0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"2023070613574133700_CIT0026","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023070613574133700_CIT0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/JID.2015.406","article-title":"IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing","volume":"136","author":"Rak","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2023070613574133700_CIT0028","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1038\/ncomms11394","article-title":"Epidermal Notch1 recruits ROR\u03b3(+) group 3 innate lymphoid cells to orchestrate normal skin repair","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"key":"2023070613574133700_CIT0029","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"2023070613574133700_CIT0030","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2008.11.001","article-title":"Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense","volume":"29","author":"Satoh-Takayama","year":"2008","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0031","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12240","article-title":"Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria","volume":"498","author":"Hepworth","year":"2013","journal-title":"Nature"},{"key":"2023070613574133700_CIT0032","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2018.12.031","article-title":"Homeostatic control of sebaceous glands by innate lymphoid cells regulates commensal bacteria equilibrium","volume":"176","author":"Kobayashi","year":"2019","journal-title":"Cell"},{"key":"2023070613574133700_CIT0033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/thoraxjnl-2019-213613","article-title":"RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock","volume":"75","author":"Zhang","year":"2020","journal-title":"Thorax"},{"key":"2023070613574133700_CIT0034","doi-asserted-by":"crossref","first-page":"108997","DOI":"10.1016\/j.celrep.2021.108997","article-title":"A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression","volume":"35","author":"Kastenschmidt","year":"2021","journal-title":"Cell Rep"},{"key":"2023070613574133700_CIT0035","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1053\/j.gastro.2020.08.051","article-title":"Group 2 innate lymphoid cells coordinate damage response in the stomach","volume":"159","author":"Meyer","year":"2020","journal-title":"Gastroenterology"},{"key":"2023070613574133700_CIT0036","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/mi.2013.33","article-title":"IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism","volume":"7","author":"Eken","year":"2014","journal-title":"Mucosal Immunol"},{"key":"2023070613574133700_CIT0037","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"2023070613574133700_CIT0038","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3423","article-title":"Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity","volume":"20","author":"Kim","year":"2014","journal-title":"Nat Med"},{"key":"2023070613574133700_CIT0039","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrrheum.2016.218","article-title":"Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases","volume":"13","author":"Shikhagaie","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2023070613574133700_CIT0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u201cinflammatory\u201d type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat Immunol"},{"key":"2023070613574133700_CIT0041","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.169.1.443","article-title":"New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25","volume":"169","author":"Hurst","year":"2002","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0042","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.4278","article-title":"A distinct innate lymphoid cell population regulates tumor-associated T cells","volume":"23","author":"Crome","year":"2017","journal-title":"Nat Med"},{"key":"2023070613574133700_CIT0043","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.kint.2019.07.019","article-title":"Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia\/reperfusion injury","volume":"97","author":"Cao","year":"2020","journal-title":"Kidney Int"},{"key":"2023070613574133700_CIT0044","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","article-title":"Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response","volume":"54","author":"Golebski","year":"2021","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20191520","article-title":"ILC2s are the predominant source of intestinal ILC-derived IL-10","volume":"217","author":"Bando","year":"2020","journal-title":"J Exp Med"},{"key":"2023070613574133700_CIT0046","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023070613574133700_CIT0047","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"2023070613574133700_CIT0048","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.4049\/jimmunol.2100661","article-title":"Searching for the elusive regulatory innate lymphoid cell","volume":"207","author":"Jegatheeswaran","year":"2021","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0049","first-page":"415","article-title":"Pathophysiology of reperfusion injury","volume":"17","author":"Cowled","year":"2011","journal-title":"Mech Vasc Dis: Textbook Vasc Special"},{"key":"2023070613574133700_CIT0050","doi-asserted-by":"crossref","first-page":"6305439","DOI":"10.1155\/2017\/6305439","article-title":"Innate immune response in kidney ischemia\/reperfusion injury: potential target for therapy","volume":"2017","author":"Kezi\u0107","year":"2017","journal-title":"J Immunol Res"},{"key":"2023070613574133700_CIT0051","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/SHK.0000000000000044","article-title":"Neutrophils\u2014a key component of ischemia-reperfusion injury","volume":"40","author":"Schofield","year":"2013","journal-title":"Shock"},{"key":"2023070613574133700_CIT0052","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1172\/JCI200112080","article-title":"Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure","volume":"108","author":"Burne","year":"2001","journal-title":"J Clin Invest"},{"key":"2023070613574133700_CIT0053","doi-asserted-by":"crossref","first-page":"F525","DOI":"10.1152\/ajprenal.2000.279.3.F525","article-title":"Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice","volume":"279","author":"Rabb","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023070613574133700_CIT0054","doi-asserted-by":"crossref","first-page":"F319","DOI":"10.1152\/ajprenal.00432.2002","article-title":"Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury","volume":"285","author":"Yokota","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023070613574133700_CIT0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a015461","article-title":"Effector mechanisms of rejection","volume":"3","author":"Moreau","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2023070613574133700_CIT0056","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2023070613574133700_CIT0057","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1600-6143.2008.02300.x","article-title":"New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells","volume":"8","author":"Li","year":"2008","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0058","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1111\/ajt.12445","article-title":"Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance","volume":"13","author":"Hu","year":"2013","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0059","doi-asserted-by":"crossref","first-page":"13508","DOI":"10.1073\/pnas.1903165116","article-title":"Treg-mediated prolonged survival of skin allografts without immunosuppression","volume":"116","author":"Pilat","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023070613574133700_CIT0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/2040620713489842","article-title":"Treatment and management of graft-versus-host disease: improving response and survival","volume":"4","author":"Garnett","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"2023070613574133700_CIT0061","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023070613574133700_CIT0062","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12185-015-1785-1","article-title":"State-of-the-art acute and chronic GVHD treatment","volume":"101","author":"Jamil","year":"2015","journal-title":"Int J Hematol"},{"key":"2023070613574133700_CIT0063","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"2023070613574133700_CIT0064","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood.V82.7.2216.2216","article-title":"Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation","volume":"82","author":"Soiffer","year":"1993","journal-title":"Blood"},{"key":"2023070613574133700_CIT0065","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"key":"2023070613574133700_CIT0066","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1704165","article-title":"Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors","volume":"32","author":"Yamasaki","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"2023070613574133700_CIT0067","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early natural killer cell reconstitution predicts overall survival in T cell-replete allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023070613574133700_CIT0068","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.leukres.2011.11.009","article-title":"The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation","volume":"36","author":"Tanaka","year":"2012","journal-title":"Leuk Res"},{"key":"2023070613574133700_CIT0069","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"2023070613574133700_CIT0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.celrep.2014.05.011","article-title":"NK cell receptor NKp46 regulates graft-versus-host disease","volume":"7","author":"Ghadially","year":"2014","journal-title":"Cell Rep"},{"key":"2023070613574133700_CIT0071","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"key":"2023070613574133700_CIT0072","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fimmu.2020.01534","article-title":"Cytotoxicity of donor natural killer cells to allo-reactive T cells are related with acute graft-vs.-host-disease following allogeneic stem cell transplantation","volume":"11","author":"Sheng","year":"2020","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0073","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbmt.2007.12.497","article-title":"Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies","volume":"14","author":"Chang","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023070613574133700_CIT0074","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fimmu.2016.00595","article-title":"Relation between acute GVHD and NK cell subset reconstitution following allogeneic stem cell transplantation","volume":"7","author":"Ullrich","year":"2016","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2017.00109","article-title":"Development of three different NK cell subpopulations during immune reconstitution after pediatric allogeneic hematopoietic stem cell transplantation: prognostic markers in GvHD and viral infections","volume":"8","author":"Huenecke","year":"2017","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0076","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"key":"2023070613574133700_CIT0077","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/JLB.5A1019-522RR","article-title":"Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation","volume":"111","author":"Piperoglou","year":"2022","journal-title":"J Leukoc Biol"},{"key":"2023070613574133700_CIT0078","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcyt.2021.10.011","article-title":"Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease","volume":"24","author":"Kroeze","year":"2022","journal-title":"Cytotherapy"},{"key":"2023070613574133700_CIT0079","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0080","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1182\/bloodadvances.2019000176","article-title":"Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease","volume":"3","author":"Hazenberg","year":"2019","journal-title":"Blood Adv"},{"key":"2023070613574133700_CIT0081","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/bloodadvances.2020001514","article-title":"Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD","volume":"5","author":"Bruce","year":"2021","journal-title":"Blood Adv"},{"key":"2023070613574133700_CIT0082","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI91816","article-title":"Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease","volume":"127","author":"Bruce","year":"2017","journal-title":"J Clin Invest"},{"key":"2023070613574133700_CIT0083","volume-title":"Organ replacement in Canada: CORR annual statistics","author":"Canadian Institute for Health Information.","year":"2019"},{"key":"2023070613574133700_CIT0084","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"2023070613574133700_CIT0085","article-title":"Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients","volume":"119(8), e2116588119","author":"Ishiyama","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023070613574133700_CIT0086","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1111\/j.1600-6143.2008.02431.x","article-title":"Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation","volume":"8","author":"Hadaya","year":"2008","journal-title":"Am J Transplant"},{"issue":"21","key":"2023070613574133700_CIT0087","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153175","article-title":"NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant","volume":"6","author":"Pickering","year":"2021","journal-title":"JCI Insight"},{"key":"2023070613574133700_CIT0088","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","article-title":"Interferon-\u03b3 production by tubulointerstitial human CD56 bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression","volume":"92","author":"Law","year":"2017","journal-title":"Kidney Int"},{"key":"2023070613574133700_CIT0089","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1681\/ASN.2016080877","article-title":"IL-33-Mediated expansion of type 2 innate lymphoid cells protects from progressive glomerulosclerosis","volume":"28","author":"Riedel","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2023070613574133700_CIT0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/15353702221147561","article-title":"Reduced type 3 innate lymphoid cells related to worsening kidney function in renal dysfunction","volume":"248","author":"Pan","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"2023070613574133700_CIT0091","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.4049\/jimmunol.181.11.7489","article-title":"NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury","volume":"181","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0092","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.4049\/jimmunol.1500651","article-title":"Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by anti-Asialo-GM1 antibody","volume":"195","author":"Victorino","year":"2015","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0093","first-page":"E13","article-title":"Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023070613574133700_CIT0094","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.4049\/jimmunol.1300358","article-title":"TLR2 signaling in tubular epithelial cells regulates NK cell recruitment in kidney ischemia-reperfusion injury","volume":"191","author":"Kim","year":"2013","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0096","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0097","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/TP.0000000000000183","article-title":"The histology of kidney transplant failure: a long-term follow-up study","volume":"98","author":"Naesens","year":"2014","journal-title":"Transplantation"},{"key":"2023070613574133700_CIT0098","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.kint.2018.08.041","article-title":"In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection","volume":"95","author":"Yagisawa","year":"2019","journal-title":"Kidney Int"},{"key":"2023070613574133700_CIT0099","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1681\/ASN.2020040433","article-title":"Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection","volume":"32","author":"Koenig","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2023070613574133700_CIT0100","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3389\/fimmu.2019.01877","article-title":"Specialized roles of human natural killer cell subsets in kidney transplant rejection","volume":"10","author":"Kildey","year":"2019","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0101","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1600-6143.2011.03621.x","article-title":"KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation","volume":"11","author":"van Bergen","year":"2011","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0102","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/01.TP.0000083896.91215.C7","article-title":"Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch","volume":"76","author":"Vampa","year":"2003","journal-title":"Transplantation"},{"key":"2023070613574133700_CIT0103","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1681\/ASN.2017070774","article-title":"Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury","volume":"29","author":"Cao","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2023070613574133700_CIT0104","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1681\/ASN.2014050479","article-title":"IL-25 elicits innate lymphoid cells and multipotent progenitor type 2 cells that reduce renal ischemic\/reperfusion injury","volume":"26","author":"Huang","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2023070613574133700_CIT0105","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1681\/ASN.2016121272","article-title":"IL233, a Novel IL-2 and IL-33 hybrid cytokine, ameliorates renal injury","volume":"28","author":"Stremska","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2023070613574133700_CIT0106","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fimmu.2019.00826","article-title":"Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury","volume":"10","author":"Cameron","year":"2019","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0107","first-page":"241","article-title":"The roles of innate immune cells in liver injury and regeneration","volume":"4","author":"Dong","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"2023070613574133700_CIT0108","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/cmi.2015.96","article-title":"Liver natural killer cells: subsets and roles in liver immunity","volume":"13","author":"Peng","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"2023070613574133700_CIT0109","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.it.2015.11.003","article-title":"Migration and tissue tropism of innate lymphoid cells","volume":"37","author":"Kim","year":"2016","journal-title":"Trends Immunol"},{"key":"2023070613574133700_CIT0110","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4049\/jimmunol.163.4.2314","article-title":"The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns","volume":"163","author":"Doherty","year":"1999","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(98)80206-7","article-title":"Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes","volume":"28","author":"Norris","year":"1998","journal-title":"J Hepatol"},{"key":"2023070613574133700_CIT0112","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"2023070613574133700_CIT0113","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41421-020-0157-z","article-title":"Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human","volume":"6","author":"Zhao","year":"2020","journal-title":"Cell Discov"},{"key":"2023070613574133700_CIT0114","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.4049\/jimmunol.1402756","article-title":"Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells","volume":"194","author":"Marquardt","year":"2015","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","article-title":"Human liver-resident CD56(bright)\/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways","volume":"66","author":"Hudspeth","year":"2016","journal-title":"J Autoimmun"},{"key":"2023070613574133700_CIT0116","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.immuni.2018.12.024","article-title":"Liver-resident NK cells control antiviral activity of hepatic T cells via the PD-1-PD-L1 axis","volume":"50","author":"Zhou","year":"2019","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0117","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/eji.201646559","article-title":"Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver","volume":"46","author":"Harmon","year":"2016","journal-title":"Eur J Immunol"},{"key":"2023070613574133700_CIT0118","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.0901362","article-title":"Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state","volume":"184","author":"Lassen","year":"2010","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0119","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.173.10.6072","article-title":"Negative regulation of NK cell activities by inhibitory receptor CD94\/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection","volume":"173","author":"Jinushi","year":"2004","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0120","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/hep.26008","article-title":"Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysis","volume":"57","author":"Graubardt","year":"2013","journal-title":"Hepatology"},{"key":"2023070613574133700_CIT0121","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/j.gastro.2004.08.055","article-title":"Negative regulation of liver regeneration by innate immunity (natural killer cells\/interferon-gamma)","volume":"127","author":"Sun","year":"2004","journal-title":"Gastroenterology"},{"key":"2023070613574133700_CIT0122","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.27245","article-title":"TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk","volume":"60","author":"Bi","year":"2014","journal-title":"Hepatology"},{"key":"2023070613574133700_CIT0123","doi-asserted-by":"crossref","first-page":"26157","DOI":"10.1038\/srep26157","article-title":"CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver","volume":"6","author":"Stegmann","year":"2016","journal-title":"Sci Rep"},{"key":"2023070613574133700_CIT0124","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4049\/jimmunol.1601818","article-title":"Cutting edge: human CD49e-NK cells are tissue resident in the liver","volume":"198","author":"Aw Yeang","year":"2017","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0125","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.22080","article-title":"Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation","volume":"16","author":"Moroso","year":"2010","journal-title":"Liver Transpl"},{"key":"2023070613574133700_CIT0126","doi-asserted-by":"crossref","first-page":"921212","DOI":"10.3389\/fimmu.2022.921212","article-title":"Human hepatic CD56bright NK cells display a tissue-resident transcriptional profile and enhanced ability to kill allogenic CD8+ T cells","volume":"13","author":"Jameson","year":"2022","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/TP.0000000000002322","article-title":"Liver perfusate natural killer cells from deceased brain donors and association with acute cellular rejection after liver transplantation: a time-to-rejection analysis","volume":"103","author":"Pagano","year":"2019","journal-title":"Transplantation"},{"key":"2023070613574133700_CIT0128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trim.2015.07.006","article-title":"Immune monitoring of immunosuppression withdrawal of liver transplant recipients","volume":"33","author":"Garc\u00eda de la Garza","year":"2015","journal-title":"Transpl Immunol"},{"key":"2023070613574133700_CIT0129","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.4049\/jimmunol.1601424","article-title":"Eomeshi NK cells in human liver are long-lived and do not recirculate but can be replenished from the circulation","volume":"197","author":"Cuff","year":"2016","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/gutjnl-2015-309395","article-title":"STAT4-associated natural killer cell tolerance following liver transplantation","volume":"66","author":"Jamil","year":"2017","journal-title":"Gut"},{"key":"2023070613574133700_CIT0131","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1499-3872(11)60065-9","article-title":"Donor liver natural killer cells alleviate liver allograft acute rejection in rats","volume":"10","author":"Yu","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2023070613574133700_CIT0132","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1600-6143.2005.00995.x","article-title":"IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses","volume":"5","author":"Obara","year":"2005","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0133","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.intimp.2012.03.007","article-title":"IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion","volume":"13","author":"Feng","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"2023070613574133700_CIT0134","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10495-008-0234-5","article-title":"Blockade of the Fas\/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver","volume":"13","author":"Nakajima","year":"2008","journal-title":"Apoptosis"},{"key":"2023070613574133700_CIT0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"key":"2023070613574133700_CIT0136","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1189\/jlb.3A0516-225R","article-title":"Murine liver-resident group 1 innate lymphoid cells regulate optimal priming of anti-viral CD8+ T cells","volume":"101","author":"Krueger","year":"2017","journal-title":"J Leukoc Biol"},{"key":"2023070613574133700_CIT0137","doi-asserted-by":"crossref","first-page":"eabi6112","DOI":"10.1126\/sciimmunol.abi6112","article-title":"Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability","volume":"7","author":"Fumagalli","year":"2022","journal-title":"Sci Immunol"},{"key":"2023070613574133700_CIT0138","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2019.11.004","article-title":"Type 1 innate lymphoid cells protect mice from acute liver injury via interferon-\u03b3 secretion for upregulating Bcl-xL expression in hepatocytes","volume":"52","author":"Nabekura","year":"2020","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0139","doi-asserted-by":"crossref","first-page":"899525","DOI":"10.3389\/fimmu.2022.899525","article-title":"Type 1 innate lymphoid cells are proinflammatory effector cells in ischemia-reperfusion injury of steatotic livers","volume":"13","author":"Kang","year":"2022","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0140","doi-asserted-by":"crossref","first-page":"953240","DOI":"10.3389\/fimmu.2022.953240","article-title":"Potential correlation of allograft infiltrating group 2 innate lymphoid cells with acute rejection after liver transplantation","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0141","doi-asserted-by":"crossref","first-page":"869365","DOI":"10.3389\/fimmu.2022.869365","article-title":"ILC2s expanded by exogenous IL-33 regulate CD45+CD11b+F4\/80high macrophage polarization to alleviate hepatic ischemia-reperfusion injury","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0142","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0143","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/hep.28492","article-title":"P2X1-regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration","volume":"63","author":"Kudira","year":"2016","journal-title":"Hepatology"},{"key":"2023070613574133700_CIT0144","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2015.08.023","article-title":"ROR\u03b3t(+) IL-22-producing NKp46(+) cells protect from hepatic ischemia reperfusion injury in mice","volume":"64","author":"Eggenhofer","year":"2016","journal-title":"J Hepatol"},{"key":"2023070613574133700_CIT0145","doi-asserted-by":"crossref","first-page":"e62853","DOI":"10.1371\/journal.pone.0062853","article-title":"IL-22-producing ROR\u03b3t-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis","volume":"8","author":"Matsumoto","year":"2013","journal-title":"PLoS One"},{"key":"2023070613574133700_CIT0146","doi-asserted-by":"crossref","first-page":"85","DOI":"10.12688\/f1000research.12493.1","article-title":"Intestinal failure: a review","volume":"7","author":"Allan","year":"2018","journal-title":"F1000Res"},{"key":"2023070613574133700_CIT0147","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ajt.12979","article-title":"Intestinal transplant registry report: global activity and trends","volume":"15","author":"Grant","year":"2015","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0148","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOG.0000000000000358","article-title":"Intestinal transplantation: a review","volume":"33","author":"Loo","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"2023070613574133700_CIT0149","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1600-6143.2012.04332.x","article-title":"Immunologic challenges in small bowel transplantation","volume":"12","author":"Berger","year":"2012","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ajt.13435","article-title":"Innate lymphoid cells groups 1 and 3 in the epithelial compartment of functional human intestinal allografts","volume":"16","author":"Talayero","year":"2016","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0151","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/tri.13609","article-title":"Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long-term in human intestinal grafts\u2014a descriptive study","volume":"33","author":"G\u00f3mez-Massa","year":"2020","journal-title":"Transpl Int"},{"key":"2023070613574133700_CIT0152","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1097\/TP.0000000000001593","article-title":"Long-term persistence of innate lymphoid cells in the gut after intestinal transplantation","volume":"101","author":"Weiner","year":"2017","journal-title":"Transplantation"},{"key":"2023070613574133700_CIT0153","doi-asserted-by":"crossref","first-page":"101288","DOI":"10.1016\/j.trim.2020.101288","article-title":"Acute cellular rejection in small-bowel transplantation impairs NCR+ innate lymphoid cell subpopulation 3\/interleukin 22 axis","volume":"60","author":"Pucci Molineris","year":"2020","journal-title":"Transpl Immunol"},{"key":"2023070613574133700_CIT0154","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/ajt.16163","article-title":"Type 3 innate lymphoid cells are associated with a successful intestinal transplant","volume":"21","author":"Kang","year":"2021","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0155","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaci.2016.07.043","article-title":"Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69-CD56dim cells","volume":"139","author":"Marquardt","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2023070613574133700_CIT0156","doi-asserted-by":"crossref","first-page":"e0145961","DOI":"10.1371\/journal.pone.0145961","article-title":"Characterization and quantification of innate lymphoid cell subsets in human lung","volume":"11","author":"de Grove","year":"2016","journal-title":"PLoS One"},{"key":"2023070613574133700_CIT0157","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ajt.12630","article-title":"Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection","volume":"14","author":"Greenland","year":"2014","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0158","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healun.2007.11.571","article-title":"Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation","volume":"27","author":"Fildes","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2023070613574133700_CIT0159","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137047","article-title":"Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury","volume":"131","author":"Calabrese","year":"2021","journal-title":"J Clin Invest"},{"key":"2023070613574133700_CIT0160","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/ajt.14257","article-title":"Cytotoxicity of natural killer cells activated through NKG2D contributes to the development of bronchiolitis obliterans in a murine heterotopic tracheal transplant model","volume":"17","author":"Kawakami","year":"2017","journal-title":"Am J Transplant"},{"issue":"24","key":"2023070613574133700_CIT0161","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164603","article-title":"NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes","volume":"7","author":"Calabrese","year":"2022","journal-title":"JCI Insight"},{"key":"2023070613574133700_CIT0162","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.healun.2021.01.449","article-title":"Natural killer cells recognize pulmonary epithelial stress molecules during primary graft dysfunction","volume":"40","author":"Aminian","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2023070613574133700_CIT0163","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1164\/rccm.201209-1749OC","article-title":"Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells","volume":"187","author":"Jungraithmayr","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2023070613574133700_CIT0164","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/ajt.14295","article-title":"HLA mismatching favoring host-versus-graft NK cell activity via KIR3DL1 is associated with improved outcomes following lung transplantation","volume":"17","author":"Greenland","year":"2017","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0165","doi-asserted-by":"crossref","first-page":"e21799","DOI":"10.1371\/journal.pone.0021799","article-title":"IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease","volume":"6","author":"Taube","year":"2011","journal-title":"PLoS One"},{"key":"2023070613574133700_CIT0166","doi-asserted-by":"crossref","first-page":"110051","DOI":"10.1016\/j.celrep.2021.110051","article-title":"ILC3s control airway inflammation by limiting T cell responses to allergens and microbes","volume":"37","author":"Teng","year":"2021","journal-title":"Cell Rep"},{"key":"2023070613574133700_CIT0167","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/rccm.201906-1113OC","article-title":"Lung innate lymphoid cell composition is altered in primary graft dysfunction","volume":"201","author":"Monticelli","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2023070613574133700_CIT0168","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/ajt.17084","article-title":"Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells","volume":"22","author":"Guo","year":"2022","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0169","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1164\/rccm.201302-0295OC","article-title":"Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax","volume":"188","author":"Kwon","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2023070613574133700_CIT0170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201612-2427OC","article-title":"Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2023070613574133700_CIT0171","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2023070613574133700_CIT0172","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0173","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2023070613574133700_CIT0174","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128241","article-title":"Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction","volume":"4","author":"Onyema","year":"2019","journal-title":"JCI Insight"},{"key":"2023070613574133700_CIT0175","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41467-017-02023-z","article-title":"Alternative activation generates IL-10 producing type 2 innate lymphoid cells","volume":"8","author":"Seehus","year":"2017","journal-title":"Nat Commun"},{"key":"2023070613574133700_CIT0176","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/ajt.15701","article-title":"IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allografts","volume":"20","author":"Tanaka","year":"2020","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0177","doi-asserted-by":"crossref","first-page":"15781","DOI":"10.1038\/ncomms15781","article-title":"Type-2 innate lymphoid cells control the development of atherosclerosis in mice","volume":"8","author":"Newland","year":"2017","journal-title":"Nat Commun"},{"key":"2023070613574133700_CIT0178","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.7150\/thno.51648","article-title":"Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"2023070613574133700_CIT0179","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/s41598-020-61903-5","article-title":"Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"2023070613574133700_CIT0180","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fimmu.2020.00802","article-title":"Unique phenotypes of heart resident type 2 innate lymphoid cells","volume":"11","author":"Deng","year":"2020","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0181","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3389\/fimmu.2019.00634","article-title":"Non-cytotoxic cardiac innate lymphoid cells are a resident and quiescent type 2-commited population","volume":"10","author":"Bracamonte-Baran","year":"2019","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0182","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0041-1345(97)00026-2","article-title":"The time pattern of organ infiltration and distribution of natural killer cells and macrophages in the course of acute graft rejection after allogeneic heart transplantation in the rat","volume":"29","author":"Dresske","year":"1997","journal-title":"Transplant Proc"},{"key":"2023070613574133700_CIT0183","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1016\/j.transproceed.2009.08.060","article-title":"Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection","volume":"41","author":"Feng","year":"2009","journal-title":"Transplant Proc"},{"key":"2023070613574133700_CIT0184","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/87880","article-title":"Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-\/- mice","volume":"7","author":"Maier","year":"2001","journal-title":"Nat Med"},{"key":"2023070613574133700_CIT0185","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.4049\/jimmunol.179.10.6416","article-title":"The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection","volume":"179","author":"Kim","year":"2007","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0186","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/ajt.16690","article-title":"The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation","volume":"21","author":"Lin","year":"2021","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0187","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.117.030435","article-title":"Genetic and functional profiling of CD16-dependent natural killer activation identifies patients at higher risk of cardiac allograft vasculopathy","volume":"137","author":"Paul","year":"2018","journal-title":"Circulation"},{"key":"2023070613574133700_CIT0188","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.4049\/jimmunol.175.5.3424","article-title":"NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts","volume":"175","author":"Uehara","year":"2005","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0189","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2023070613574133700_CIT0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0000000000001937","article-title":"\u03b2 cell replacement therapy: the next 10 years","volume":"102","author":"Schuetz","year":"2018","journal-title":"Transplantation"},{"key":"2023070613574133700_CIT0191","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1007\/s00125-021-05565-6","article-title":"Interactions between islets and regulatory immune cells in health and type 1 diabetes","volume":"64","author":"Budd","year":"2021","journal-title":"Diabetologia"},{"key":"2023070613574133700_CIT0192","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm1296","article-title":"NK cells promote islet allograft tolerance via a perforin-dependent mechanism","volume":"11","author":"Beilke","year":"2005","journal-title":"Nat Med"},{"key":"2023070613574133700_CIT0193","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/ajt.14265","article-title":"Regulatory B cell-dependent islet transplant tolerance is also natural killer cell dependent","volume":"17","author":"Schuetz","year":"2017","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0194","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.immuni.2017.10.015","article-title":"Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production","volume":"47","author":"Dalmas","year":"2017","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0195","doi-asserted-by":"crossref","first-page":"e12305","DOI":"10.15252\/emmm.202012305","article-title":"IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival","volume":"12","author":"Huang","year":"2020","journal-title":"EMBO Mol Med"},{"key":"2023070613574133700_CIT0196","doi-asserted-by":"crossref","first-page":"669787","DOI":"10.3389\/fimmu.2021.669787","article-title":"IL-33 drives expansion of type 2 innate lymphoid cells and regulatory T cells and protects mice from severe, acute colitis","volume":"12","author":"Ngo Thi Phuong","year":"2021","journal-title":"Front Immunol"},{"key":"2023070613574133700_CIT0197","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","article-title":"Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria","volume":"43","author":"Bernink","year":"2015","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0198","doi-asserted-by":"crossref","first-page":"C369","DOI":"10.1152\/ajpcell.00515.2020","article-title":"Immunoengineering approaches for cytokine therapy","volume":"321","author":"Mansurov","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"2023070613574133700_CIT0199","doi-asserted-by":"crossref","first-page":"e1008140","DOI":"10.1371\/journal.ppat.1008140","article-title":"IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis","volume":"15","author":"Tripathi","year":"2019","journal-title":"PLoS Pathog"},{"key":"2023070613574133700_CIT0200","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1182\/blood-2010-09-303081","article-title":"Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue","volume":"117","author":"Tang","year":"2011","journal-title":"Blood"},{"key":"2023070613574133700_CIT0201","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.1005641107","article-title":"Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity","volume":"107","author":"Cella","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023070613574133700_CIT0202","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2147\/JAA.S304126","article-title":"Healthy and patient Type 2 innate lymphoid cells are differently affected by in vitro culture conditions","volume":"14","author":"Falquet","year":"2021","journal-title":"J Asthma Allergy"},{"key":"2023070613574133700_CIT0203","doi-asserted-by":"crossref","first-page":"208ra","DOI":"10.1126\/scitranslmed.3006702","article-title":"Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry","volume":"5","author":"Horowitz","year":"2013","journal-title":"Sci Transl Med"},{"key":"2023070613574133700_CIT0204","doi-asserted-by":"crossref","first-page":"e4709","DOI":"10.1371\/journal.pone.0004709","article-title":"Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity","volume":"4","author":"Stauch","year":"2009","journal-title":"PLoS One"},{"key":"2023070613574133700_CIT0205","doi-asserted-by":"crossref","first-page":"e0161618","DOI":"10.1371\/journal.pone.0161618","article-title":"CD52-Negative NK cells are abundant in the liver and less susceptible to alemtuzumab treatment","volume":"11","author":"Hotta","year":"2016","journal-title":"PLoS One"},{"key":"2023070613574133700_CIT0206","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1111\/ajt.12838","article-title":"The combination of anti-NKG2D and CTLA-4 Ig therapy prolongs islet allograft survival in a murine model","volume":"14","author":"Pawlick","year":"2014","journal-title":"Am J Transplant"},{"key":"2023070613574133700_CIT0207","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.170.3.1304","article-title":"Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance","volume":"170","author":"Min","year":"2003","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0208","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J Immunol"},{"key":"2023070613574133700_CIT0209","doi-asserted-by":"crossref","first-page":"582939","DOI":"10.3389\/fimmu.2020.582939","article-title":"Macrophages in organ transplantation","volume":"11","author":"Ordikhani","year":"2020","journal-title":"Front Immunol"},{"issue":"24","key":"2023070613574133700_CIT0210","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96455","article-title":"Eosinophils promote inducible NOS-mediated lung allograft acceptance","volume":"2","author":"Onyema","year":"2017","journal-title":"JCI Insight"},{"key":"2023070613574133700_CIT0211","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/tri.13549","article-title":"B cells in transplant tolerance and rejection: friends or foes?","volume":"33","author":"Schmitz","year":"2020","journal-title":"Transpl Int"},{"key":"2023070613574133700_CIT0212","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.immuni.2021.12.014","article-title":"Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation","volume":"55","author":"Cautivo","year":"2022","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0213","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41422-020-0323-8","article-title":"Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity","volume":"30","author":"Klose","year":"2020","journal-title":"Cell Res"},{"key":"2023070613574133700_CIT0214","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.4373","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells","volume":"23","author":"Rauber","year":"2017","journal-title":"Nat Med"},{"key":"2023070613574133700_CIT0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and interferon-\u03b3 counter-regulate group 2 innate lymphoid cell activation during immune perturbation","volume":"43","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"2023070613574133700_CIT0216","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"2023070613574133700_CIT0217","doi-asserted-by":"crossref","first-page":"1249288","DOI":"10.1126\/science.1249288","article-title":"Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis","volume":"343","author":"Mortha","year":"2014","journal-title":"Science"},{"key":"2023070613574133700_CIT0218","doi-asserted-by":"crossref","first-page":"a015495","DOI":"10.1101\/cshperspect.a015495","article-title":"Lessons and limits of mouse models","volume":"3","author":"Chong","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2023070613574133700_CIT0219","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-981-16-8387-9_11","article-title":"The road from mouse to human ILCs: a perspective of understanding the roles of ILCs in disease","volume":"1365","author":"Spits","year":"2022","journal-title":"Adv Exp Med Biol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxad050\/50412909\/uxad050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/213\/1\/23\/50829963\/uxad050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/213\/1\/23\/50829963\/uxad050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T14:01:02Z","timestamp":1688652062000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/213\/1\/23\/7146986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":219,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,4,29]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxad050","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,4,29]]}}}